Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Bone Biologics Corporation BBLG

Full chart Compare
Set alert

Price alert · BBLG

All alert types
0.35 USD -0.02 (-4.69%)

At closeNov 4, 2026, 4:23 AM EST

0.36 +0.01 +1.81%

Pre-market · Nov 4, 4:23 AM ET

0.3517 Day range 0.3713
0.3517 52-week range 2.39
YTD
-75.62%
1 year
-82.76%

Financial health

Altman Z-Score

-18.52 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B-2 / 5 overall

  • DCF 5
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 5

Valuation

P/E -0.5×
FY 2016: -0.1×FY 2017: -0.5×FY 2018: -1.0×FY 2019: -49.5×FY 2020: -92.9×FY 2021: -67.9×FY 2022: -4.9×FY 2023: -0.8×FY 2024: -1.2×FY 2025: -0.5×
FY 2016 5y median -1.2× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 0.3×
FY 2016: -0.4×FY 2017: -0.4×FY 2018: -0.5×FY 2019: -14.2×FY 2020: -12.3×FY 2021: 16.6×FY 2022: 1.2×FY 2023: 2.5×FY 2024: 2.5×FY 2025: 0.3×
FY 2016 5y median 2.5× FY 2025
P/FCF -0.6×
FY 2016: -0.5×FY 2017: -1.1×FY 2018: -1.1×FY 2019: -52.0×FY 2020: -396×FY 2021: -88.8×FY 2022: -2.0×FY 2023: -0.7×FY 2024: -2.1×FY 2025: -0.6×
FY 2016 5y median -2.0× FY 2025
EV/EBITDA 1.2×
FY 2016: -0.6×FY 2017: -4.2×FY 2018: -4.5×FY 2019: -73.7×FY 2020: -219×FY 2021: -127×FY 2022: 0.5×FY 2023: 8.6×FY 2024: 48.8×FY 2025: 1.2×
FY 2016 5y median 1.2× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -158.0%
FY 2016: -211.5%FY 2017: -92.9%FY 2018: -88.7%FY 2019: -1.9%FY 2020: -0.3%FY 2021: -1.1%FY 2022: -49.6%FY 2023: -133.9%FY 2024: -48.2%FY 2025: -158.0%
FY 2016 5y median -49.6% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -57.8%
FY 2016: 309.4%FY 2017: 84.0%FY 2018: 51.5%FY 2019: 28.9%FY 2020: 13.3%FY 2021: -24.5%FY 2022: -25.0%FY 2023: -307.9%FY 2024: -118.0%FY 2025: -57.8%
FY 2016 5y median -57.8% FY 2025
ROIC -60.2%
FY 2016: -5111.7%FY 2017: 1581.2%FY 2018: -694.6%FY 2019: 446.9%FY 2020: 41.9%FY 2021: -16.8%FY 2022: -61.6%FY 2023: -324.4%FY 2024: -121.1%FY 2025: -60.2%
FY 2016 5y median -61.6% FY 2025
ROA -53.6%
FY 2016: -2659.5%FY 2017: -886.3%FY 2018: -425.7%FY 2019: -11109.8%FY 2020: 0.0%FY 2021: -24.1%FY 2022: -17.5%FY 2023: -239.4%FY 2024: -106.5%FY 2025: -53.6%
FY 2016 5y median -53.6% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income 23.3%
FY 2016: -70.2%FY 2017: 87.1%FY 2018: -6.2%FY 2019: 12.3%FY 2020: 66.3%FY 2021: -33.7%FY 2022: -232.3%FY 2023: -157.2%FY 2024: 55.3%FY 2025: 23.3%
FY 2016 FY 2025
EPS (diluted) 45.1%
FY 2016: -40.8%FY 2017: 73.9%FY 2018: 51.0%FY 2019: 97.9%FY 2020: 46.7%FY 2021: -4.7%FY 2022: 16.5%FY 2023: -9.0%FY 2024: 85.8%FY 2025: 45.1%
FY 2016 FY 2025
Free Cash Flow 34.8%
FY 2016: -106.6%FY 2017: 54.6%FY 2018: -23.3%FY 2019: 20.8%FY 2020: 86.9%FY 2021: -187.8%FY 2022: -190.3%FY 2023: -167.9%FY 2024: 56.8%FY 2025: 34.8%
FY 2016 FY 2025

Financial Health

Current Ratio 13.8×
FY 2016: 0.5×FY 2017: 0.8×FY 2018: 0.1×FY 2019: 0.1×FY 2020: 0.0×FY 2021: 66.8×FY 2022: 3.3×FY 2023: 4.5×FY 2024: 10.2×FY 2025: 13.8×
FY 2016 5y median 10.2× FY 2025
Quick Ratio 13.8×
FY 2016: 0.5×FY 2017: 0.8×FY 2018: 0.1×FY 2019: 0.1×FY 2020: 0.0×FY 2021: 66.8×FY 2022: 3.3×FY 2023: 4.5×FY 2024: 10.2×FY 2025: 13.8×
FY 2016 5y median 10.2× FY 2025
Debt / Equity 0.0×
FY 2016: -1.0×FY 2017: -1.0×FY 2018: -1.0×FY 2019: -1.0×FY 2020: -0.9×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 1.7×
FY 2016: -0.4×FY 2017: -2.9×FY 2018: -2.9×FY 2019: -4.6×FY 2020: -14.2×FY 2021: 8.3×FY 2022: 10.0×FY 2023: -6.3×FY 2024: -31.0×FY 2025: 1.7×
FY 2016 5y median 1.7× FY 2025
Interest Coverage 0.0×
FY 2016: -7.8×FY 2017: -0.6×FY 2018: -2.3×FY 2019: -2.5×FY 2020: -0.8×FY 2021: -1.4×FY 2022: -5.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 37.5%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: -78.1%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31